Acriptega Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg Acriptega is a combination antiretroviral medicine used in the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection. It contains three active ingredients that work together to reduce the amount of HIV in the body. By controlling viral replication, Acriptega helps protect the immune system and supports long-term management of HIV when taken consistently as prescribed.

Effects & Benefits Helps lower the amount of HIV in the bloodstream. Supports the immune system by reducing viral activity. Helps increase and maintain healthy CD4 cell counts. Reduces the risk of HIV-related complications. Provides a convenient once-daily treatment in a single tablet. Supports long-term viral suppression when combined with regular medical care.